IPO FILING: Critical Homecare Solutions Holdings, Inc.

Photo of Douglas A. McIntyre
By Douglas A. McIntyre Published
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.

Critical Homecare Solutions Holdings, Inc. has filed to come public via an IPO.  For filing purposes it has said it will sell up to $125 million in common stock under the ticker "CHCS" on NASDAQ.  The initial filing shows UBS Investment Bank as the lead underwriter and co-managers are listed as Jefferies & Co. and Piper Jaffray. 

The company operates in two segments: home infusion therapy and home nursing.  It is a provider of comprehensive home infusion therapy services to patients suffering from acute or chronic conditions and it claims to deliver over 400,000 infusion pharmaceuticals and equipment each year to patients in the home through our 33 infusion locations in 14 states.  It also provides over 350,000 nursing and therapy visits and 500,000 private duty nursing hours each year to patients in the home through our 32 home nursing locations in three states.

Its filing also notes that it currently provide customized local clinical care to over 19,000 patients through its branch network and have relationships with approximately 450 payors, including insurers, managed care organizations and government payors. In the year ended 2006 and the six months ended June 30, 2007, we generated pro forma net revenue of $176.1 million and $92.8 million, respectively.

If you want a summary of the company, it is the boots on the ground for the homecare business in the long-term care segment of the health and insurance business.  The home health care sector is estimated by Frost & Sullivan to have accounted for between approximately $47 billion and $58 billion of overall health care spending in the United States in 2005 and is projected to grow at a compound annual growth rate of approximately 8% from 2005 to 2010. Home health care services can provide a less expensive alternative to the provision of similar treatments in hospitals, nursing facilities or on an outpatient basis.  The company has just completed three smaller acquisitions, and based upon the fragmented marketplace in the homecare market there are hundreds or more companies that could be rolled up.

Jon C. Ogg
October 11, 2007

Photo of Douglas A. McIntyre
About the Author Douglas A. McIntyre →

Douglas A. McIntyre is the co-founder, chief executive officer and editor in chief of 24/7 Wall St. and 24/7 Tempo. He has held these jobs since 2006.

McIntyre has written thousands of articles for 24/7 Wall St. He is an expert on corporate finance, the automotive industry, media companies and international finance. He has edited articles on national demographics, sports, personal income and travel.

His work has been quoted or mentioned in The New York Times, The Wall Street Journal, Los Angeles Times, The Washington Post, NBC News, Time, The New Yorker, HuffPost USA Today, Business Insider, Yahoo, AOL, MarketWatch, The Atlantic, Bloomberg, New York Post, Chicago Tribune, Forbes, The Guardian and many other major publications. McIntyre has been a guest on CNBC, the BBC and television and radio stations across the country.

A magna cum laude graduate of Harvard College, McIntyre also was president of The Harvard Advocate. Founded in 1866, the Advocate is the oldest college publication in the United States.

TheStreet.com, Comps.com and Edgar Online are some of the public companies for which McIntyre served on the board of directors. He was a Vicinity Corporation board member when the company was sold to Microsoft in 2002. He served on the audit committees of some of these companies.

McIntyre has been the CEO of FutureSource, a provider of trading terminals and news to commodities and futures traders. He was president of Switchboard, the online phone directory company. He served as chairman and CEO of On2 Technologies, the video compression company that provided video compression software for Adobe’s Flash. Google bought On2 in 2009.

Continue Reading

Top Gaining Stocks

CBOE Vol: 1,568,143
PSKY Vol: 12,285,993
STX Vol: 7,378,346
ORCL Vol: 26,317,675
DDOG Vol: 6,247,779

Top Losing Stocks

LKQ
LKQ Vol: 4,367,433
CLX Vol: 13,260,523
SYK Vol: 4,519,455
MHK Vol: 1,859,865
AMGN Vol: 3,818,618